glp 1 age restrictions Prescriptions for Obesity Medications Among Adolescents Aged 12–17 Years with Obesity — United States, 2018–2023 What Age Can You Take
Description
For the small cohort of AOM patients who do switch, tirzepatide is the most common agent, and nearly half opt to pay cash for Zepbound, often through LillyDirects direct-to-consumer platform
Either gives you the structure this phase demands without guessing at the details yourself
I am an endocrinologist by training and spent 20 years researching diabetes and obesity at Indiana University while also seeing patients
Injectable tirzepatide achieves higher blood concentrations more reliably than oral formulations, making it slightly more potent for most patients
